How can we make the pain go away? Public policies to manage pain at the end of life.

The Gerontologist
Sara Imhof, Brian Kaskie

Abstract

The continued undertreatment of pain at the end of life is a substantive public health problem that has not been resolved through increased public awareness, the issuance of clinical guidance for providers, or expanded organizational commitments. In this forum, we illuminate the role of public policies in promoting pain management. We review federal and state policies and consider empirical evaluations that compared the quality of state policies and the factors that contributed to their formation. We resolve that any organized interest in improving end-of-life care should begin by focusing on the development and expansion of those state policies that support the provision of evidence-based medicine for reducing the amount of pain an individual experiences at the end of life. Although empirical research is needed to determine which particular aspects of state pain policy are most critical and how these policies can be implemented most effectively, any organized effort that advances state medical board activity or another state policy would appear to be making an important step toward making the pain at the end of life go away.

References

Aug 1, 1988·Quality Assurance and Utilization Review : Official Journal of the American College of Utilization Review Physicians·B L Galusha
Jan 1, 1973·Archives of Internal Medicine·G M Green
Jan 1, 1995·Health Affairs·D Yankelovich
Apr 1, 1993·The Annals of Thoracic Surgery·J P IguidbashianH A Berkoff
Feb 10, 1998·Health Affairs·J K Iglehart
Jun 20, 1998·JAMA : the Journal of the American Medical Association·J Morrison, P Wickersham
Jun 25, 1998·Health Affairs·M S Sparer
Jan 23, 1999·Health Affairs·A WellJ Holahan
Jan 23, 1999·JAMA : the Journal of the American Medical Association·P A SingerM Kelner
Jul 27, 1999·Annals of Internal Medicine·T R FriedM A Drickamer
Nov 14, 2000·JAMA : the Journal of the American Medical Association·K E SteinhauserJ A Tulsky
Jul 19, 2001·Clinics in Geriatric Medicine·K A Herr, L Garand
Feb 15, 2002·Journal of Pain and Symptom Management·David E JoransonJ David Haddox
Jun 18, 2002·Journal of the American Geriatrics Society·UNKNOWN AGS Panel on Persistent Pain in Older Persons
Jul 3, 2002·Drugs & Aging·Michael Gordon
Jan 8, 2003·Oncology Nursing Forum·Anne M Reb
May 24, 2003·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Aaron M GilsonMartha A Maurer
May 27, 2004·Health Affairs·James FloryEzekiel Emanuel
Oct 28, 2004·Health Affairs·John HolahanJoshua M Wiener
Jul 12, 2005·Current Pain and Headache Reports·Sharon M Weinstein
Aug 9, 2005·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Scott M Fishman
Aug 11, 2005·Journal of Health Politics, Policy and Law·Bruce Spitz, John Abramson
Dec 13, 2005·Social Science & Medicine·Edward Alan Millar
Jan 6, 2006·The New England Journal of Medicine·Timothy E Quill, Diane E Meier
Jul 21, 2006·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·Sharon R KaufmanAnn J Russ
Apr 11, 2008·Journal of Pain and Symptom Management·Marianne Ahlner-ElmqvistStein Kaasa
Sep 27, 2008·Journal of Health Politics, Policy and Law·Sara L Imhof, Brian Kaskie

❮ Previous
Next ❯

Citations

Jan 11, 2012·The Gerontologist·Tina MaschiMary B Morrissey
Dec 15, 2015·Journal of Pain & Palliative Care Pharmacotherapy·Monika BawaK L N Rao
Nov 9, 2010·Journal of the American Geriatrics Society·Lydia W Li, Yeates Conwell
Mar 31, 2016·Journal of Aging & Social Policy·Brian P KaskieMark S Kaplan
Jul 10, 2012·Nursing Ethics·Dawn L Denny, Ginny W Guido
Nov 30, 2018·American Journal of Public Health·Jacob Gross, Debra B Gordon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.